Navarro: Trump may impose 232 tariffs on pharmaceutical products
I'm PortAI, I can summarize articles.
White House advisor Navarro stated that U.S. President Trump may impose tariffs on pharmaceutical products under Section 232. This news caused Pfizer's stock price to drop by more than 0.7%, UnitedHealth to decline by more than 0.4%, while Amgen, Johnson & Johnson, and AstraZeneca ADR rose by 0.6%, 0.1%, and 0.4%, respectively. Investment should be approached with caution, and this article does not constitute personal investment advice
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments